Christian Bryant

Jul 2, 2024 | onlinelibrary.wiley.com | Eric Li |Esther Jones |Christian Bryant |Tracy King

What is the new aspect of your work? This is the first study to report the efficacy and safety of PCAB (prednisone, cyclophosphamide, doxorubicin, carmustine), a single-day polychemotherapy regimen in relapsed and refractory multiple myeloma (RRMM) in the era of novel therapies. What is the central finding of your work?

Mar 20, 2023 | pn.bmj.com | Antonia J Clarke |Antonia S Carroll |Christian Bryant |Gabor M Halmagyi

http://orcid.org/0000-0002-5603-9399Antonia J Clarke1,2, Antonia S Carroll2,3, Christian Bryant2,4, Gabor M Halmagyi1,2 1 Department of Neurology, Royal Prince Alfred Hospital, Camperdown, New South Wales, Australia 2 Faculty of Medicine and Health, The University of Sydney, Sydney, New South Wales, Australia 3 Westmead Amyloidosis Centre, Westmead Hospital, Westmead, New South Wales, Australia 4 Institute of Haematology, Royal Prince Alfred Hospital, Camperdown, New South Wales, Australia...